Medicare Incentives For Quality Drugs Should Not Wait For US FDA Ratings, Experts Tell Congress

Medicare payment for higher quality drugs would help abate shortages, experts with the Brookings Institution, Civica Rx and University of California say. Brookings’ Wosińska explains how hospitals could identify quality generic injectable drug manufacturers without waiting for FDA quality ratings.